Castle Biosciences, Inc. - Common stock (CSTL)

Management lifted its outlook, but one key test still awaits Medicare coverage.

Castle Biosciences (NASDAQ:CSTL) raised its full-year revenue outlook after reporting 24% third-quarter revenue growth, driven primarily by demand for its TissueCypher test. The company reported revenue of $102.9 million for the quarter and now expects 2026 revenue of $385 million to $395 million,

Castle Biosciences (NASDAQ:CSTL) reported continued momentum in its core diagnostic franchises during the second quarter, prompting the company to raise its outlook by more than the amount of its reported beat, according to CFO Frank Stokes. Stokes said the company’s DecisionDx-Melanoma and TissueC

Revenue hit $103.5 million, up 20% YoY, as TissueCypher surged 63%.

Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported results. The company raised its full-year revenue outlook to $365 million to $375 million, from a previous

Castle (CSTL) Q1 2026 Earnings Transcript

DigitalBridge Group operates at the forefront of digital infrastructure, managing assets critical to global connectivity and data growth.

e.l.f. Beauty delivers cosmetics and skin care through a multi-channel model, with recent filings highlighting strong revenue growth.

Baidu delivers online marketing, cloud, and AI-powered services to businesses and consumers across China’s digital economy.

Castle Biosciences (CSTL) Earnings Transcript

This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets.

This semiconductor company provides integrated RF and mixed-signal solutions for broadband, wireless, and industrial connectivity.

Castle Biosciences' bullish structure is strengthening as momentum builds ahead of a possible breakout.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.